Patient-Powered Biospecimens and Data
Procure Human Biospecimens Prospectively
Having confidence in your results requires access to clinically relevant biospecimen types and comprehensive datasets to make accurate conclusions. But sample criteria are increasingly specific, patient populations are harder and harder to reach, and study designs can seem impossible.
By leveraging an engaging direct-to-patient approach coupled with on-demand specimen procurement and data collection capabilities, you’ll touch even the hardest to reach populations. Our fully integrated service solution is simple and has you covered from start to finish—including same-day delivery.
& Data Collection
& Data Collection
Human Biospecimen Types
Our specimen procurement capabilities are minimally invasive and are further supported by in-home centrifugation, supplementary laboratory services (e.g., isolation of peripheral blood mononuclear cells (PBMCs), HLA typing, comprehensive clinical testing), and temperature-sensitive shipments according to your study protocol.
Blood-Derived Biofluids and Products
A custom-tailored approach means an enhanced ability to recruit participants and procure biospecimens prospectively. You’ll get more accurate data points per sample, increased study design flexibility, and an expedited time to completion.
Same-day specimen procurement and delivery
Nationwide patient member community to meet complex inclusion/exclusion criteria
Medical record-verified eligibility and pre-screening
Access to electronic medical records, health histories, patient-reported datasets
Long-term follow-up with study participants
We Specialize in These Conditions
Behind our therapeutic experience are patient member communities made up of more than 60,000 total members ready to advance science and medicine for the conditions they live with.
Get Samples for My Research
Compliance & Quality Assured
Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval of all study protocols, specific study documentation, and study participant facing information. Both Advarra and WCG IRB are organized and operates in compliance with: FDA, OHRP, and International Conference on Harmonization (ICH).
Sanguine operates under an electronic informed consent process which executes 21 CFR part 11 compliant e-signatures, and Sanguine systems interacting with study participant information are HIPAA-compliant.